A detailed history of State Of Wisconsin Investment Board transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 40,185 shares of SNDX stock, worth $525,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,185
Previous 52,287 23.15%
Holding current value
$525,619
Previous $1.07 Million 27.96%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$17.93 - $24.81 $216,988 - $300,250
-12,102 Reduced 23.15%
40,185 $773,000
Q2 2024

Aug 14, 2024

BUY
$18.82 - $23.79 $208,638 - $263,735
11,086 Added 26.91%
52,287 $1.07 Million
Q1 2024

May 14, 2024

SELL
$19.71 - $24.57 $740,248 - $922,775
-37,557 Reduced 47.69%
41,201 $980,000
Q4 2023

Feb 12, 2024

BUY
$11.39 - $21.67 $276,799 - $526,624
24,302 Added 44.63%
78,758 $1.7 Million
Q3 2023

Nov 14, 2023

BUY
$14.52 - $21.77 $107,448 - $161,098
7,400 Added 15.73%
54,456 $790,000
Q2 2023

Aug 14, 2023

SELL
$19.35 - $22.31 $103,193 - $118,979
-5,333 Reduced 10.18%
47,056 $984,000
Q1 2023

May 15, 2023

SELL
$20.66 - $28.98 $21,858 - $30,660
-1,058 Reduced 1.98%
52,389 $1.11 Million
Q4 2022

Feb 14, 2023

BUY
$20.64 - $26.24 $149,309 - $189,820
7,234 Added 15.65%
53,447 $1.36 Million
Q3 2022

Nov 14, 2022

BUY
$18.51 - $24.79 $48,847 - $65,420
2,639 Added 6.06%
46,213 $1.11 Million
Q2 2022

Aug 15, 2022

SELL
$13.64 - $19.48 $199,498 - $284,914
-14,626 Reduced 25.13%
43,574 $838,000
Q4 2021

Feb 11, 2022

SELL
$15.23 - $22.47 $249,772 - $368,508
-16,400 Reduced 21.98%
58,200 $1.27 Million
Q3 2021

Nov 12, 2021

SELL
$13.87 - $19.8 $19,418 - $27,720
-1,400 Reduced 1.84%
74,600 $1.43 Million
Q2 2021

Aug 12, 2021

BUY
$13.42 - $25.18 $301,950 - $566,550
22,500 Added 42.06%
76,000 $1.31 Million
Q1 2021

May 17, 2021

BUY
$19.28 - $24.59 $52,056 - $66,393
2,700 Added 5.31%
53,500 $1.2 Million
Q4 2020

Feb 03, 2021

SELL
$15.1 - $26.44 $105,700 - $185,080
-7,000 Reduced 12.11%
50,800 $1.13 Million
Q3 2020

Nov 16, 2020

BUY
$13.39 - $17.48 $235,664 - $307,648
17,600 Added 43.78%
57,800 $853,000
Q2 2020

Aug 12, 2020

BUY
$8.94 - $20.98 $31,290 - $73,430
3,500 Added 9.54%
40,200 $596,000
Q1 2020

May 06, 2020

BUY
$6.65 - $12.03 $43,890 - $79,398
6,600 Added 21.93%
36,700 $403,000
Q3 2019

Nov 12, 2019

BUY
$7.47 - $10.76 $81,423 - $117,284
10,900 Added 56.77%
30,100 $225,000
Q2 2019

Aug 14, 2019

BUY
$4.9 - $9.31 $1,960 - $3,724
400 Added 2.13%
19,200 $179,000
Q1 2019

May 13, 2019

BUY
$4.26 - $6.86 $18,744 - $30,184
4,400 Added 30.56%
18,800 $99,000
Q4 2018

Feb 11, 2019

BUY
$3.6 - $8.42 $51,840 - $121,248
14,400 New
14,400 $64,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.